Squarepoint
STOK icon

Squarepoint’s Stoke Therapeutics STOK Stock Holding History

Squarepoint’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$959K Buy
+29,310
New +$941K ﹤0.01% 2928
2025
Q3 		– Sell
-23,458
Closed -$266K – 4977
2025
Q2 		$266K Buy
+23,458
New +$223K ﹤0.01% 3776
2025
Q1 		– Sell
-120,242
Closed -$1.33M – 5381
2024
Q4 		$1.33M Buy
120,242
+7,575
+7% +$93.1K ﹤0.01% 2801
2024
Q3 		$1.38M Buy
112,667
+97,625
+649% +$1.38M ﹤0.01% 2352
2024
Q2 		$203K Sell
15,042
-36,055
-71% -$487K ﹤0.01% 3654
2024
Q1 		$690K Buy
51,097
+32,001
+168% +$194K ﹤0.01% 2840
2023
Q4 		$100K Buy
19,096
+3,886
+26% +$16.6K ﹤0.01% 3754
2023
Q3 		$59.9K Buy
+15,210
New +$100K ﹤0.01% 3617
2023
Q2 		– Sell
-17,851
Closed -$149K – 3994
2023
Q1 		$149K Buy
+17,851
New +$161K ﹤0.01% 2894
2021
Q3 		– Sell
-6,495
Closed -$219K – 3407
2021
Q2 		$219K Sell
6,495
-4,217
-39% -$149K ﹤0.01% 2757
2021
Q1 		$416K Buy
+10,712
New +$610K ﹤0.01% 2157
2020
Q4 		– Sell
-10,837
Closed -$363K – 3247
2020
Q3 		$363K Buy
+10,837
New +$309K ﹤0.01% 1661
2020
Q1 		– Sell
-20,286
Closed -$574K – 2483
2019
Q4 		$574K Sell
20,286
-1,413
-7% -$35.5K ﹤0.01% 1688
2019
Q3 		$466K Buy
+21,699
New +$605K ﹤0.01% 1659

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint's STOK Position: Q2 2026 in Review

Squarepoint opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 29,310 shares worth $959K. The stake represents ﹤0.01% of the portfolio and ranks #2928 among its holdings. This is a return to the name: Squarepoint previously reported a position in STOK as recently as Q2 2025.

Squarepoint first reported a position in STOK in Q3 2019 and has held it in 14 quarters since. The position peaked at $1.38M in Q3 2024. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Squarepoint held 29,310 shares of Stoke Therapeutics worth $959K as of Q2 2026.
  • Stoke Therapeutics was a new Squarepoint position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2928 holding.
  • Squarepoint first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 14 quarters since.
  • Squarepoint's Stoke Therapeutics position peaked at $1.38M in Q3 2024.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.